ReviewEndocrine2019

A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.

Sandra M McLachlan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.